ALRM's Piotroski F-Score of 4/9 indicates weak financial health, signaling potential instability despite moderate profitability and growth. The absence of an Altman Z-Score raises concern about default risk, particularly given a high debt/equity ratio of 1.20. While the company exhibits strong earnings growth (17.9% YoY) and consistent earnings beats (average surprise of 18.19% over last 4 quarters), its valuation at 18.94x P/E is elevated relative to peers and the broader sector. The Graham Number ($30.76) and intrinsic value estimate ($72.57) suggest a significant premium to conservative fair value, driven by growth expectations. Insider selling activity over the past six months further tempers optimism.